1 Min Read
March 23 (Reuters) - Clovis Oncology Inc:
* CLOVIS ONCOLOGY INITIATES EARLY ACCESS PROGRAM FOR RUCAPARIB AS TREATMENT AND AS MAINTENANCE THERAPY IN RECURRENT OVARIAN CANCER IN EUROPE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.